arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

GeneDx Holdings Corp.

WGS

$77.19 ▲ +7.51 (+10.78%) at close

8 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Bearish

auto_awesome

Analytical Summary

GeneDx Holdings Corp. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.2B

Dividend Yield —

Revenue Growth 40.0% ↘

Op. Margin -3.1% ↗

ROIC -3.6% ↗

FCF / Share $0.50 ↗

Trailing P/E —

Price / Book 7.3x

FCF Yield 0.7%

Debt / Equity 0.18

info Valuation on last close. End-of-day price, Aug 7, 2026.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$427.54M

↑ +40.0% —

Net Income Profit after all expenses

$-21.02M

↑ +59.8% —

Operating Margin Operating profit as % of sales

-3.1%

↑ +59.8% 23th

FCF / Share Free cash flow per share

$0.50

↑ +139.4% —

Long-Term Debt Long-term obligations

$54.54M

↑ +5.1% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Financial Health ↑

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	40.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+400%)	50.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+535%)	-13.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-271%)	10.6% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+33%)	18.3% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+129%)	-8.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-207%)	—	—
EPS Growth YoY (%)	62.4% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	73.2% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	86.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	29.1% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	100.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	82.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	59.8% Excellent ↑ Excellent Improving Year-over-year change in net income	70.3% Excellent ↑ Excellent Improving Year-over-year change in net income	68.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-123.7% Weak ↑ Weak Improving Year-over-year change in net income	-1.7% Weak Weak Year-over-year change in net income	-712.5% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	83.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	76.1% Excellent Excellent Year-over-year change in free cash flow	48.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—
Revenue CAGR 3Y (%)	22.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	12.9% Good ↑ Good Improving Compound annual revenue growth over 3 years	4.1% Caution Caution Compound annual revenue growth over 3 years	6.2% Fair Fair Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	19.0% Excellent Excellent Compound annual revenue growth over 5 years	9.3% Good Good Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	-3.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-120%)	-7.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-151%)	-89.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-694%)	-284.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1997%)	-210.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1502%)	-134.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1000%)	-15.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-203%)	—
Effective Tax Rate (%) (%)	0.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	8.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-4.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-141%)	-17.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-243%)	-86.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-823%)	-233.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2049%)	-115.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1064%)	-134.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1222%)	-15.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-226%)	—
FCF Margin (%) (%)	3.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-11.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-91.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-139.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-94.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-65.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-15.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	-0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-3.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-63.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-235.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-111.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	77.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	34.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-2.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-43.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-136.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-80.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-96.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-6.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	-21.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-242%)	-77.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-614%)	-216.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1543%)	-63.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-522%)	73.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+387%)	33.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+123%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Debt to Equity (x)	0.18x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-71%)	0.21x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-65%)	0.25x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-59%)	0.02x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	0.03x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	-0.06x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-110%)	—	—
Interest Coverage (x)	-2.04x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3.48x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-59.39x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-345.58x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-157.37x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-97.81x Weak Weak Operating income divided by interest expense Optimal: > 5x	-38.84x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-50.45M	$-33.30M	$-43.43M	$-117.68M	$-389.57M	$-89.16M	—	—
Debt / EBITDA (x)	-15.69x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-3.39x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.35x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.01x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.03x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.08x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$14.93	$11.36	$8.33	$22.93	$65.45	—	—	—
Basic EPS, GAAP (USD)	$-0.73	$-1.94	$-7.23	$-53.63	$-75.67	$-1.57M	$-8.80M	—
Free Cash Flow per Share (USD)	$0.50	$-1.26	$-7.63	$-31.88	$-61.63	—	—	—
Book Value per Share (USD)	$10.54	$8.75	$8.78	$21.55	$119.70	—	—	—
Tangible Book Value per Share (USD)	$4.31	$3.09	$2.13	$5.70	$119.70	—	—	—
Basic Weighted Avg Shares (shares)	28.64M	26.89M	24.31M	10.24M	3.24M	154	4	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$159.38M	$143.15M	$123.52M	$68.33M	$382.26M	$100.67M	—	—
LT Debt (USD)	$54.54M	$51.91M	$56.25M	$6.25M	$11.00M	$18.97M	—	—
Total Equity (USD)	$308.18M	$245.25M	$228.02M	$253.71M	$388.10M	$-330.05M	$-88.71M	$-55.97M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$427.54M	$305.45M	$202.57M	$234.69M	$212.19M	$179.32M	$196.17M	—
Depreciation Expense (USD)	$9.60M	$7.90M	$19.70M	$50.00M	$21.81M	$11.73M	$6.41M	—
Net Income, GAAP (USD)	$-21.02M	$-52.29M	$-175.77M	$-548.98M	$-245.39M	$-241.34M	$-29.70M	—
Operating Cash Flow (USD)	$33.28M	$-28.50M	$-180.15M	$-319.15M	$-190.43M	$-93.13M	$-18.73M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 26 quarters

GeneDx Holdings Corp.

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare WGS with peers